CN106389580A - 一种改善智能减退的胶囊及制备方法 - Google Patents
一种改善智能减退的胶囊及制备方法 Download PDFInfo
- Publication number
- CN106389580A CN106389580A CN201610486870.3A CN201610486870A CN106389580A CN 106389580 A CN106389580 A CN 106389580A CN 201610486870 A CN201610486870 A CN 201610486870A CN 106389580 A CN106389580 A CN 106389580A
- Authority
- CN
- China
- Prior art keywords
- parts
- capsule
- minute
- minutes
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims description 23
- 241000522620 Scorpio Species 0.000 claims abstract description 24
- 239000009490 scorpio Substances 0.000 claims abstract description 24
- 241000222336 Ganoderma Species 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 22
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 21
- 235000000381 ginkgo Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 235000008434 ginseng Nutrition 0.000 claims abstract description 20
- 235000005035 ginseng Nutrition 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 210000000582 Semen Anatomy 0.000 claims description 30
- 239000000706 filtrate Substances 0.000 claims description 25
- 241000283956 Manis Species 0.000 claims description 23
- 241000237636 Pheretima Species 0.000 claims description 23
- 241000270295 Serpentes Species 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 18
- 239000004576 sand Substances 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000004140 cleaning Methods 0.000 claims description 14
- 239000004375 Dextrin Substances 0.000 claims description 11
- 229920001353 Dextrin Polymers 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 11
- 239000012267 brine Substances 0.000 claims description 11
- 235000019425 dextrin Nutrition 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 4
- 241000218628 Ginkgo Species 0.000 claims 4
- 240000007594 Oryza sativa Species 0.000 claims 1
- 240000002883 Ginkgo biloba Species 0.000 abstract description 18
- 240000004678 Panax pseudoginseng Species 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract 2
- 229940023019 Aconite Drugs 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000270273 Ptyas dhumnades Species 0.000 abstract 1
- 241001165494 Rhodiola Species 0.000 abstract 1
- 241001233061 earthworms Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 14
- 239000003814 drug Substances 0.000 description 12
- 210000004369 Blood Anatomy 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 208000006673 Asthma Diseases 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000002216 Heart Anatomy 0.000 description 7
- 210000004185 Liver Anatomy 0.000 description 7
- 210000004072 Lung Anatomy 0.000 description 6
- 241000209094 Oryza Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 208000002173 Dizziness Diseases 0.000 description 5
- 206010019468 Hemiplegia Diseases 0.000 description 5
- 206010022437 Insomnia Diseases 0.000 description 5
- 210000000952 Spleen Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 4
- 210000001015 Abdomen Anatomy 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N Benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010022114 Injury Diseases 0.000 description 4
- 206010025482 Malaise Diseases 0.000 description 4
- 230000000414 obstructive Effects 0.000 description 4
- 206010001897 Alzheimer's disease Diseases 0.000 description 3
- 206010003549 Asthenia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000668709 Dipterocarpus costatus Species 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 206010019233 Headache Diseases 0.000 description 3
- 210000003491 Skin Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 210000001367 Arteries Anatomy 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N Coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010016256 Fatigue Diseases 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N Nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000008425 Protein Deficiency Diseases 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 210000003462 Veins Anatomy 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 201000000736 amenorrhea Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial Effects 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 229940095076 benzaldehyde Drugs 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000008286 diarrhea Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 230000002522 swelling Effects 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000002936 tranquilizing Effects 0.000 description 2
- -1 (-)-Neferine Chemical compound 0.000 description 1
- AJPXZTKPPINUKN-FIRIVFDPSA-N (1R)-1-[[4-hydroxy-3-[[(1R)-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol Chemical compound C1=CC(OC)=CC=C1C[C@@H]1C2=CC(OC=3C(=CC=C(C[C@@H]4C5=CC(O)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C AJPXZTKPPINUKN-FIRIVFDPSA-N 0.000 description 1
- XCUCMLUTCAKSOZ-FIRIVFDPSA-N 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[[(1R)-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenol Chemical compound C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-FIRIVFDPSA-N 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000269 Abscess Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010001954 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 206010007554 Cardiac failure Diseases 0.000 description 1
- 206010007625 Cardiogenic shock Diseases 0.000 description 1
- 240000004499 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 1
- 235000002548 Cistus Nutrition 0.000 description 1
- 241000984090 Cistus Species 0.000 description 1
- 241000270292 Colubridae Species 0.000 description 1
- 206010010252 Concentric sclerosis Diseases 0.000 description 1
- 208000006111 Contracture Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 229960003067 Cystine Drugs 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N Daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- 206010012305 Demyelination Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000001786 Gonorrhea Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019280 Heart failure Diseases 0.000 description 1
- 208000002948 Hematoma, Subdural, Chronic Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- WZRCQWQRFZITDX-UHFFFAOYSA-N Higenamine Chemical compound C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 WZRCQWQRFZITDX-UHFFFAOYSA-N 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 208000003906 Hydrocephalus Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 206010020993 Hypoglycaemia Diseases 0.000 description 1
- 208000000038 Hypoparathyroidism Diseases 0.000 description 1
- 210000003026 Hypopharynx Anatomy 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 210000003127 Knee Anatomy 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024381 Leukodystrophy Diseases 0.000 description 1
- 206010068202 Leukodystrophy Diseases 0.000 description 1
- XCUCMLUTCAKSOZ-JSOSNVBQSA-N Liensinine Natural products C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-JSOSNVBQSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 206010027378 Mental retardation Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010027599 Migraine Diseases 0.000 description 1
- 208000008085 Migraine Disorders Diseases 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004296 Neuralgia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010053643 Neurodegenerative disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001170115 Rhodiola kirilowii Species 0.000 description 1
- 241000208225 Rhus Species 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N Rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 208000005687 Scabies Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000002667 Subdural Hematoma Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000002435 Tendons Anatomy 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 210000001685 Thyroid Gland Anatomy 0.000 description 1
- 229940098465 Tincture Drugs 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 208000002670 Vitamin B 12 Deficiency Diseases 0.000 description 1
- 201000001203 Wilson disease Diseases 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000000146 antalgic Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000002490 cerebral Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N cinnamic aldehyde Natural products O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 125000002871 cinnamic aldehydes group Chemical group 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000003034 coal gas Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000002354 daily Effects 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000029578 entry into host Effects 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000002218 hypoglycaemic Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 201000006347 intellectual disability Diseases 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000607 poisoning Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive Effects 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-β-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 230000000268 renotropic Effects 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000224 toxic side effect Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 201000004810 vascular dementia Diseases 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
本发明公开了一种改善智能减退的胶囊,取下述重量配比的主要原料制备而成:人参5‑10份,全蝎4‑9份,黄芪10‑20份,银杏叶10‑20份,桃仁5‑15份,地龙7‑13份,灵芝4‑10份,肉桂5‑10份,狮子七3‑7份,乌鞘蛇2‑4份,穿山甲5‑10份,川乌3‑8份,莲子心5‑15份。本发明药材药源易得,成本低廉,所选药材多为药性平和之物,长期使用也不会给使用者增加经济和身体上的负担。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种改善智能减退的胶囊及制备方法。
背景技术
智能减退是一种常见的症状,如果是在18岁以后出现称为痴呆,18岁之前出现的则称为精神发育迟滞,儿童及成人皆可发病,其发病率随年龄的增长而增高。据统计,65岁以上人群痴呆患病率为4%~6%,80岁以上老人患病率可高达20%。智能减退是一种综合征,在很多疾病中只是一个症状,因此,它的病因繁多、复杂,有一部分病因引起的智能减退是可治或能被控制的,所以早期明确诊断及治疗非常重要。
原因:常见的引起智能减退的病因包括:老年性痴呆、脑血管病、中毒(如煤气、酒精、重金属、有机化合物等)、维生素B12缺乏、颅内肿瘤、慢性硬膜下血肿、脑外伤、颅内感染(如结核、细菌、病毒等)、甲状腺或甲状旁腺功能低下、长期低血糖、脑积水、癫痫;还有很多少见疾病,如脑白质营养不良、肝豆状核变性、亨亭顿病等遗传性疾病;另外,还有多发性硬化、同心圆硬化等脱髓鞘疾病,进行性核上性麻痹、皮质基底节变性等变性疾病。其中最多见的是老年性痴呆和血管性痴呆。
随着经济的发展,人们渐渐意识到,中药在改善智能减退方面占有非常重要的地位,但是专利文献中,没有专门用于改善智能减退的胶囊。
发明内容
针对现有技术的不足,本发明的目的之一在于提供改善智能减退的胶囊,本发明药材药源易得,成本低廉,所选药材多为药性平和之物,长期使用也不会给使用者增加经济和身体上的负担。
本发明的另一目的就是提供上述胶囊的制备方法。
本发明的技术方案是:
改善智能减退的胶囊,取下述重量配比的主要原料制备而成:人参5-10份,全蝎4-9份,黄芪10-20份,银杏叶10-20份,桃仁5-15份,地龙7-13份,灵芝4-10份,肉桂5-10份,狮子七3-7份,乌鞘蛇2-4份,穿山甲5-10份,川乌3-8份,莲子心5-15份。
改善智能减退的胶囊,优选的方案为,取下述重量配比的主要原料制备而成:人参6-9份,全蝎5-8份,黄芪13-18份,银杏叶13-18份,桃仁8-13份,地龙9-11份,灵芝6-8份,肉桂6-9份,狮子七4-6份,乌鞘蛇2.5-3.5份,穿山甲6-9份,川乌4-7份,莲子心8-13份。
改善智能减退的胶囊,更为优选的方案为,取下述重量配比的主要原料制备而成:人参7.5份,全蝎6.5份,黄芪15份,银杏叶15份,桃仁10份,地龙10份,灵芝7份,肉桂7.5份,狮子七5份,乌鞘蛇3份,穿山甲8份,川乌5.5份,莲子心10 份。
上述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒2-6分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制3-7分钟,研磨成细末,过80-120目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡20-40分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮15-25分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于2-6℃的环境下4-8小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌5-10分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘20-40分钟,按照胶囊的加工工艺加工成胶囊。
上述胶囊的制备方法,步骤(2)待黄沙炒制滑利状态时放入穿山甲,炒3-5分钟(优选的,待黄沙炒制滑利状态时放入穿山甲,炒4分钟)。
上述胶囊的制备方法,步骤(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制4-6分钟(优选的,将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制5分钟)。
上述胶囊的制备方法,步骤(4)切碎,用淡盐水浸泡25-35分钟(优选的,切碎,用淡盐水浸泡30分钟)。
上述胶囊的制备方法,步骤(4)每次大火煮沸后转文火煎煮18-23分钟(优选的,每次大火煮沸后转文火煎煮20分钟)。
上述胶囊的制备方法,步骤(4)将混合滤液置于3-5℃的环境下5-7小时,得上清液(优选的,将混合滤液置于4℃的环境下6小时,得上清液)。
上述胶囊的制备方法,步骤(5)一边加热一边搅拌6-9分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘25-35分钟(优选的,一边加热一边搅拌7分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘30分钟)。
各原料药的药理功效分别为:
人参:主治:体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,久病虚羸,惊悸失眠,阳痿宫冷;心力衰竭,心原性休克。用于气短喘促,心悸健忘,口渴多汗,食少无力,一切急慢性疾病及失血后引起的休克、虚脱。大补元气,固脱生津,安神。治劳伤虚损,食少,倦怠,反胃吐食,大便滑泄,虚咳喘促,自汗暴脱,惊悸,健忘,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿慢惊,及久虚不复,一切气血津液不足之证。
全蝎:辛,平。归经:归肝经。功效:息风镇痉,通络止痛,攻毒散结。主治:用于肝风内动,痉挛抽搐,小儿惊风,中风口㖞,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
黄芪:黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。
银杏叶:银杏叶,为银杏科植物银杏Ginkgo biloba L.的干燥叶。具有活血化瘀,通络止痛,敛肺平喘,化浊降脂的功效。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
桃仁:果实成熟后采收,除去果肉和核壳,取出种子,晒干。全国各地普遍栽培。具有活血祛瘀,润肠通便,止咳平喘的功效。用于经闭痛经,瘕瘕痞块,肺痈肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。
地龙:功能主治: 热病惊狂、小儿惊风、咳喘、头痛目赤、咽喉肿痛、小便不通、风湿关节疼痛,半身不遂等症。外用涂丹毒、漆疮等症。1.清热息风:主治壮热惊痫,动风抽搐。2.清肺定喘:可治肺热痰咳气喘,对肺热型支气管哮喘疗效较好。3.利尿通淋:适用于湿热下注,热淋涩痛。4.通行经络:可用治热痹节肿赤痛;适当配伍也可治寒痹;配伍益气行血药常用于气虚血瘀,经络不利,偏瘫失语者。
灵芝:灵芝又称林中灵、琼珍(学名:Ganoderma Lucidum Karst)是多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘的功效,用于眩晕不眠、心悸气短、神经衰弱、虚劳咳喘,延年益寿的功效。心神不宁,失眠,惊悸。该品味甘性平,入心经,能补心血、益心气、安心神,故可用治气血不足、心神失养所致的心神不宁、失眠、惊悸、多梦、健忘、体倦神疲、食少等症。
肉桂:为樟科樟属植物肉桂的干皮、枝皮。成分:桂皮含挥发油1.89%-2.06%,其主要成分为桂皮醛,占52.92%-61.20%,还有乙酸桂皮酯,桂皮酸乙酯,苯甲醛苄酯,苯甲醛,香豆素等。药性:辛、甘,热。归肾、脾、心、肝经。功用主治:补火助阳,散寒止痛,温经通脉。主治肾阳不足,命门火衰之畏寒肢冷,腰膝酸软,阳痿遗精,小便不利或频数,短气喘促,浮肿尿少诸症;命门火衰,火不归源,戴阳、格阳,及上热下寒,面赤足冷,头晕耳鸣,口舌糜破;脾肾虚寒,脘腹冷痛,食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛,宫冷不孕,痛经闭经,产后淤滞腹痛;阴疽流注,或虚寒痈疡脓成不溃,或溃后不敛。
狮子七:为景天科红景天属植物狭叶红景天的根及根茎。成分:全草含酪醇,胡萝卜苷,红景天苷,百脉跟苷。药性:苦、涩,温。归肺、心、肝、大肠经。功用主治:养心安神,化瘀,止血。主治气虚体弱,短气乏力心悸失眠,头昏眩晕,胸闷疼痛,跌打损伤,月经不调,崩漏,吐血,痢疾,腹泻。
乌鞘蛇:为游蛇科乌梢蛇属动物乌梢蛇除去内脏的全体。成分:乌梢蛇全体含赖氨酸,亮氨酸,天冬氨酸,谷氨酸,甘氨酸,丙氨酸,苏氨酸,丝氨酸,胱氨酸,甲硫氨酸等。药性:甘,平。归肺、脾、肝经。功用主治:祛风湿,通经络,止痉。主治风湿顽痹,肌肤麻木,筋脉拘挛,肢体瘫痪,破伤风,麻风,风疹疥癣。
穿山甲:功效与作用:活血散结;通经下乳;消痈溃坚。主血瘀经闭;症瘕;风湿痹痛;乳汁不下;痈肿;瘰疬。用于经闭癓瘕,乳汁不通,痈肿疮毒,关节痹痛,麻木拘挛。
川乌:辛、苦,热;有大毒。归心、肝、肾、脾经。祛风除湿,温经止痛。用于风寒湿痹、关节疼痛、心腹冷痛、寒疝作痛。用于治疗风寒湿痹、关节疼痛等病症。一般炮制后内服。生川乌酊外用能刺激皮肤,继而产生麻木感,故外用作某些神经痛及风湿的镇痛剂。
莲子心:含莲心碱、异莲心碱、甲基莲心碱、荷叶碱、前荷叶碱、牛角花素、甲基紫堇杷灵、去甲基乌药碱。又含水犀草甙、金丝桃甙、芸香甙等黄酮类,清心火,平肝火,泻脾火,降肺火。消暑除烦,生津止渴,治目红肿。
1、本发明胶囊“注重整体”,既可改善智能减退,又可治疗偏瘫、失语、四肢麻木以及老年痴呆等,本胶囊完全根据中医中药原理制备而成,更加安全可靠,无任何毒副作用,对基体无任何刺激。
2、本发明胶囊所选药材配伍相宜,采用现代先进的制药技术制成,疗效显著,安全无毒副作用,标本兼治,值得广泛推广应用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例 1改善智能减退的胶囊,取下述重量配比的主要原料制备而成(每份取10g):人参5份,全蝎4份,黄芪10份,银杏叶10份,桃仁5份,地龙7份,灵芝4份,肉桂5份,狮子七3份,乌鞘蛇2份,穿山甲5份,川乌3份,莲子心5份。
上述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒2分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制3分钟,研磨成细末,过80目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡20分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮15分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于2℃的环境下4小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌5分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘20分钟,按照胶囊的加工工艺加工成胶囊。
实施例 2 改善智能减退的胶囊,取下述重量配比的主要原料制备而成(每份取5g):人参10份,全蝎9份,黄芪20份,银杏叶20份,桃仁15份,地龙13份,灵芝10份,肉桂10份,狮子七7份,乌鞘蛇4份,穿山甲10份,川乌8份,莲子心15份。
上述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒6分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制7分钟,研磨成细末,过120目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡40分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮25分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于6℃的环境下8小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌10分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘40分钟,按照胶囊的加工工艺加工成胶囊。
实施例 3 改善智能减退的胶囊,取下述重量配比的主要原料制备而成(每份取15g):人参6份,全蝎5份,黄芪13份,银杏叶13份,桃仁8份,地龙9份,灵芝6份,肉桂6份,狮子七4份,乌鞘蛇2.5份,穿山甲6份,川乌4份,莲子心8份。
述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒3分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制4分钟,研磨成细末,过90目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡25分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮18分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于3℃的环境下5小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌6分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘25分钟,按照胶囊的加工工艺加工成胶囊。
实施例 4 改善智能减退的胶囊,取下述重量配比的主要原料制备而成(每份取20g):人参9份,全蝎8份,黄芪18份,银杏叶18份,桃仁13份,地龙11份,灵芝8份,肉桂9份,狮子七6份,乌鞘蛇3.5份,穿山甲9份,川乌7份,莲子心13份。
上述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒5分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制6分钟,研磨成细末,过80-120目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡35分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮23分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于5℃的环境下7小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌9分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘35分钟,按照胶囊的加工工艺加工成胶囊。
实施例 5 改善智能减退的胶囊,取下述重量配比的主要原料制备而成(每份取30g):人参7.5份,全蝎6.5份,黄芪15份,银杏叶15份,桃仁10份,地龙10份,灵芝7份,肉桂7.5份,狮子七5份,乌鞘蛇3份,穿山甲8份,川乌5.5份,莲子心10 份。
上述胶囊的制备方法,步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒4分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制5分钟,研磨成细末,过100目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡30分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮20分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于4℃的环境下6小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌7分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘30分钟,按照胶囊的加工工艺加工成胶囊。
试验例 1实施例5所得改善智能减退的胶囊的临床应用:我们随机抽取了400名患者做实验(400名智能减退患者),平均分成实验组和对照组,其中女性200例,男性200例。试验之前1周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组使用实施例5所得产品,对照组服用其他改善智能减退的药物。
最佳使用方法:为使本发明达到最佳的治疗效果,制成的胶囊,每天三餐后服用,温开水送服,7天为一个疗程。
疗效评定:显效:不适症状消失;无效:症状无变化。
具体实验结果如下表:
表1:
使用本发明胶囊比其它其他治疗改善智能减退的药物疗效更加全面,经临床试验证明,本发明组合物有效率为100%,治愈率为99%,可以减轻患者的身体负担,是一种治疗智能减退的理想组合物。
Claims (10)
1.改善智能减退的胶囊,其特征在于:取下述重量配比的主要原料制备而成:人参5-10份,全蝎4-9份,黄芪10-20份,银杏叶10-20份,桃仁5-15份,地龙7-13份,灵芝4-10份,肉桂5-10份,狮子七3-7份,乌鞘蛇2-4份,穿山甲5-10份,川乌3-8份,莲子心5-15份。
2.根据权利要求 1所述的改善智能减退的胶囊,其特征在于:取下述重量配比的主要原料制备而成:人参6-9份,全蝎5-8份,黄芪13-18份,银杏叶13-18份,桃仁8-13份,地龙9-11份,灵芝6-8份,肉桂6-9份,狮子七4-6份,乌鞘蛇2.5-3.5份,穿山甲6-9份,川乌4-7份,莲子心8-13份。
3.根据权利要求1所述的改善智能减退的胶囊,其特征在于:取下述重量配比的主要原料制备而成:人参7.5份,全蝎6.5份,黄芪15份,银杏叶15份,桃仁10份,地龙10份,灵芝7份,肉桂7.5份,狮子七5份,乌鞘蛇3份,穿山甲8份,川乌5.5份,莲子心10 份。
4.根据权利要求1-3任一项所述的改善智能减退的胶囊的制备方法,其特征在于:步骤如下:
(1)将桃仁反复翻炒至酥脆,研磨成细粉待用;
(2)将锅烧热,放入干净的黄沙,待黄沙炒制滑利状态时放入穿山甲,炒2-6分钟,放入米醋,取出晾凉,研碎待用;
(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制3-7分钟,研磨成细末,过80-120目筛待用;
(4)将人参、黄芪、银杏叶、灵芝、肉桂、狮子七、川乌和莲子心用清水洗净,切碎,用淡盐水浸泡20-40分钟,过滤,滤渣中加水煎煮两次,每次大火煮沸后转文火煎煮15-25分钟,过滤,两次滤液合并得混合滤液,将混合滤液置于2-6℃的环境下4-8小时,得上清液;
(5)将步骤(1)-(3)所得物混匀,加入步骤(4)所得上清液中,一边加热一边搅拌5-10分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘20-40分钟,按照胶囊的加工工艺加工成胶囊。
5.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(2)待黄沙炒制滑利状态时放入穿山甲,炒3-5分钟(优选的,待黄沙炒制滑利状态时放入穿山甲,炒4分钟)。
6.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(3)将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制4-6分钟(优选的,将全蝎、地龙和乌鞘蛇的表面涂抹一层花生油,烤制5分钟)。
7.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(4)切碎,用淡盐水浸泡25-35分钟(优选的,切碎,用淡盐水浸泡30分钟)。
8.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(4)每次大火煮沸后转文火煎煮18-23分钟(优选的,每次大火煮沸后转文火煎煮20分钟)。
9.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(4)将混合滤液置于3-5℃的环境下5-7小时,得上清液(优选的,将混合滤液置于4℃的环境下6小时,得上清液)。
10.根据权利要求4所述的胶囊的制备方法,其特征在于:步骤(5)一边加热一边搅拌6-9分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘25-35分钟(优选的,一边加热一边搅拌7分钟后加入糊精和炼制好的蜜,继续搅拌成稠膏,将稠膏烘30分钟)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486870.3A CN106389580A (zh) | 2016-06-29 | 2016-06-29 | 一种改善智能减退的胶囊及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610486870.3A CN106389580A (zh) | 2016-06-29 | 2016-06-29 | 一种改善智能减退的胶囊及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389580A true CN106389580A (zh) | 2017-02-15 |
Family
ID=58006836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610486870.3A Pending CN106389580A (zh) | 2016-06-29 | 2016-06-29 | 一种改善智能减退的胶囊及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389580A (zh) |
-
2016
- 2016-06-29 CN CN201610486870.3A patent/CN106389580A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091234B (zh) | 一种治疗骨伤疾病的中药组合物 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN105125677A (zh) | 治疗原发性三叉神经痛的制剂丸剂的制备方法 | |
CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN104784459A (zh) | 治疗由神经衰弱引起的眩晕的中药制剂及制备方法 | |
CN106389580A (zh) | 一种改善智能减退的胶囊及制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN105267940A (zh) | 一种预防和治疗胃溃疡的中药组合物及其制备方法 | |
CN105056071A (zh) | 防治心律不齐的中药方剂及制法 | |
CN105168947A (zh) | 一种治疗肝阴不足证型胁痛的中药组合物 | |
CN105287933A (zh) | 一种医治动脉硬化的健脾益气中药制剂及制法 | |
CN105055840A (zh) | 治疗心律失常的药剂及其制备方法 | |
CN105079318A (zh) | 医治三叉神经痛的活血止痛制剂及制法 | |
CN104940551B (zh) | 一种可调节骨髓造血功能的饮品及制法 | |
CN104689205A (zh) | 一种治疗失眠多梦的中药制剂及制备方法 | |
CN104547518A (zh) | 一种防治急性心衰的中药喷剂及其制备方法 | |
CN104606537A (zh) | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 | |
CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
CN103505713B (zh) | 一种治疗营卫不和证型肌痹病的中药组合物 | |
CN102370848A (zh) | 治疗妇女因湿邪白带的中草药 | |
CN104887948A (zh) | 治疗心绞痛的中药方剂 | |
CN104491118A (zh) | 缓解脑部外伤的补脑安神饮及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |